CLARIFY COVID 19 SKIN
CLARIFY COVID 19 FULL

This is part of basic science studies into RNA biology of SARS-CoV-2 infections, with implications on virus replication at the cellular level. The TRS motif is involved in subgenomic RNA-RNA interactions, and single nucleotide substitutions may affect the mechanism. We strongly advise members of the public not to self-medicate with Ivermectin and to consult their doctor for proper treatment of COVID-19.įAKE NEWS: A three-year-old preschooler passed away from COVID-19 at KK Women’s and Children’s Hospital (KKH), and the death was deliberately not reported

CLARIFY COVID 19 SKIN

Side effects can include vomiting, stomach pain, seizures, severe skin rash and liver injury etc. Self-medicating with Ivermectin can be dangerous to one’s health, and there have been reports of patients requiring hospitalisation after doing so. To date, there is no scientific evidence from properly conducted clinical trials to demonstrate that Ivermectin is effective against COVID-19. It is not an anti-viral medicine and is not approved by HSA for use in the prevention or treatment of COVID-19. In Singapore, Ivermectin is a prescription-only medicine registered only for the treatment of parasitic worm infections.

CLARIFY COVID 19 FULL

For information regarding consumer safety, please visit For HSA’s full advisory on Lianhua Qingwen, please see:įAKE NEWS ALERT: Local websites such as “Truth Warriors” posting unverified and potentially misleading information on COVID-19 and vaccinesĬOVID-19 vaccines approved for use in Singapore have been assessed to be safe and effective by both the HSA and the Expert Committee on COVID-19 Vaccination. Please visit the latest information on COVID-19. We strongly advise members of the public to consult a doctor for management of COVID-19, and to avoid speculating and/or spreading misinformation, which may cause public alarm, and to refer to credible sources of information instead. We reserve the right to take further action if Mr Goh Meng Seng persists with this unjustified claim. Mr Goh Meng Seng has accused the Government of lying this is a serious, baseless accusation. The numbers of patients in these RCTs were not large enough, as such there is no conclusive scientific evidence to show Lianhua Qingwen can be used to prevent or treat COVID-19 in Singapore. To date, a few randomised control clinical trials (RCTs) on Lianhua Qingwen have been conducted, only in China. She cited inability to secure a suitable study site as the reason for the withdrawal. However, the Principal Investigator for the study later withdrew her application.

MOH had indeed offered to sponsor the study mentioned by Mr Goh Meng Seng, under a TCM research grant. The Ministry of Health (MOH) is aware of a Facebook post by Mr Goh Meng Seng, who noted that MOH had sponsored a study on the efficacy of the drug in treating mild COVID-19 infections, which was supposed to run from July 2020 to February 2021, and asked why the findings of that study have not been published yet.

Clarify covid 19